Skip to main content

Table 1 Inhibitory activities of amphotericin B, fluconazole, and voriconazole against clinical isolates of Cryptococcus neoformans (n = 46) from initial cerebro-spinal fluid culture

From: Correlation of anti-fungal susceptibility with clinical outcomes in patients with cryptococcal meningitis

Anti-fungal agent

Cumulative % inhibited at MIC (μg/ml)

0.06

0.12

0.25

0.5

1

2

4

8

16

32

Amphotericin B

0

0

6.5

36.9

82.6

100

    

Fluconazole

  

0

0

0

8.7

28.3

74

95.7

100

Voriconazole

8.7

52.2

91.3

100